...
首页> 外文期刊>Phytotherapy research: PTR >Effect of Zingiber officinale Supplementation on Obesity Management with Respect to the Uncoupling Protein 1-3826A > G and ss 3-adrenergic Receptor Trp64Arg Polymorphism
【24h】

Effect of Zingiber officinale Supplementation on Obesity Management with Respect to the Uncoupling Protein 1-3826A > G and ss 3-adrenergic Receptor Trp64Arg Polymorphism

机译:相对于解偶联蛋白1-3826A> G和ss 3-肾上腺素受体Trp64Arg多态性,补充姜皮对肥胖管理的影响。

获取原文
获取原文并翻译 | 示例

摘要

The present study aimed to investigate the effect of ginger (Zingiber officinale) supplementation on some obesity-associated parameters, with nutrigenetics approach. Accordingly, 80 eligible obese women (aged 18-45years) were randomly assigned to receive either ginger (2-g ginger rhizomes powder as two 1-g tablets per day) or placebo supplements (corn starch with the same amount) for 12weeks. Subjects were tested for changes in body weight, body mass index, waist and hip circumferences, body composition, appetite score, and dietary intake. Moreover, participants were genotyped for the -3826A>G and Trp64Arg polymorphisms of uncoupling protein 1 and ss 3-adrenergic receptor genes, respectively. Over 12weeks, ginger supplementation resulted in a slight but statistically significant decrease in all anthropometric measurements and total appetite score as compared with placebo group, which were more pronounced in subjects with the AA genotype for uncoupling protein 1 and Trp64Trp genotype for ss 3-adrenergic receptor gene. However, there was no significant difference in changes of body composition and total energy and macronutrients intake between groups. In conclusion, our findings suggest that ginger consumption has potential in managing obesity, accompanying with an intervention-genotype interaction effect. However, further clinical trials need to explore ginger's efficacy as an anti-obesity agent in the form of powder, extract, or its active components. Copyright (c) 2015 John Wiley & Sons, Ltd.
机译:本研究旨在通过营养遗传学方法研究生姜(姜)对某些肥胖相关参数的影响。因此,随机分配80名合格的肥胖妇女(年龄在18-45岁之间)接受姜汁(每天2克1克片剂2克姜根粉)或安慰剂补充剂(相同量的玉米淀粉),持续12周。测试受试者的体重,体重指数,腰围和臀围,身体组成,食欲得分和饮食摄入量的变化。此外,分别对参与者的解偶联蛋白1和ss 3-肾上腺素受体基因的-3826A> G和Trp64Arg多态性进行了基因分型。与安慰剂组相比,在12周的时间内,补充生姜后,所有人体测量学和总食欲评分均出现了轻微但统计学上的显着下降,在具有解偶联蛋白1的AA基因型和ss 3-肾上腺素能受体的Trp64Trp基因型的受试者中更为明显。基因。但是,两组之间的身体成分,总能量和大量营养素摄入的变化没有显着差异。总之,我们的发现表明食用生姜具有控制肥胖的潜力,并具有干预-基因型相互作用效应。但是,进一步的临床试验需要探索姜粉,提取物或其活性成分形式的抗肥胖药的功效。版权所有(c)2015 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号